Filing Details

Accession Number:
0001681622-21-000117
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-27 17:02:51
Reporting Period:
2021-12-23
Accepted Time:
2021-12-27 17:02:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1681622 Varex Imaging Corp VREX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1599398 Sunny Sanyal C/O Varex Imaging Corp.
1678 S. Pioneer Road
Salt Lake City UT 84104
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-23 8,602 $30.74 82,228 No 4 M Direct
Common Stock Disposition 2021-12-23 8,602 $32.00 73,626 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-12-23 8,602 $0.00 8,602 $30.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
61,901 2022-02-13 No 4 M Direct
Footnotes
  1. Amount of securities beneficially owned at end of reporting period reflect 2,945 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.
  2. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 16, 2021. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.03. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  3. The non-qualified stock options were subject to a three-year vesting period. One-third vested on February 13, 2016, and the remaining two-thirds vested on a pro-rata basis monthly thereafter.